The global demand for Intravenous Solutions Market is presumed to reach the market size of nearly USD 40.86 MN by 2030 from USD 15.29 MN in 2022 with a CAGR of 11.54% under the study period 2023 - 2030.
Intravenous solutions or IV fluids are special liquids injected into veins to treat patients. This route of fluid administration is used for those patients who won't take these fluids directly through their mouth. It can also be used to administer medicine or electrolytes to correct electrolyte imbalances. In addition, the intravenous route introduces medications into the circulatory system, thus making it the fastest way to deliver drugs and fluid replacement throughout the body.
Market Dynamics
The demand for intravenous solutions is higher in developing countries where malnutrition is prevalent. In addition, the increase in the prevalence of cancer and fatality rate causes an increase in demand for intravenous solutions. Furthermore, infants and older adults need intravenous solutions as they are more susceptible to diseases; thus, as life expectancy decreases each year, the demand for intravenous solutions in on a rise.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous solutions. The growth and trends of intravenous solutions industry provide a holistic approach to this study.
Market Segmentation
This section of the intravenous solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
By Composition
- Carbohydrates
- Vitamins And Minerals
- Single Dose Amino Acids
- Parenteral Lipid Emulsion
- Others
By End Users
- Hospitals And Clinics
- Ambulatory Surgery Centers
- Home Care Settings
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Intravenous Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Intravenous Solutions Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous solutions market include Amanta Healthcare Ltd., Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eurolife Healthcare Pvt Ltd, Fresenius Kabi AG, Grifols S.A., Henry Schein Inc., ICU Medical Inc., JW Life Science, OtsUKa Pharmaceutical Co. Ltd., Pfizer Inc., Salius Pharma Private Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.